AHA 2020 | Rise in Early Discharge After TAVR Has the Expected Cost

As hospitalization time after a transcatheter aortic valve replacement (TAVR) is reduced, we are observing a concomitant increase in re-hospitalizations due to conduction disorders. Early discharge is a great step, but it should be noted that conduction disorders can happen beyond 48 hours.

A few years ago, pacemaker implantation rates after discharge were about 7%; nowadays, that figure has almost been doubled.

Conduction system injury and its subsequent complete atrioventricular block is a well-known TAVR complication, whose prevalence rate varies according to prosthesis type, implantation technique, operator and center experience, etc. The worldwide trend to speed up patient discharge after TAVR has led to more indications for permanent pacemakers after the index hospitalization.

This paper, presented at the American Heart Association (AHA) 2020 Scientific Sessions and simultaneously published in JACC: Cardiovascular Interventions, describes this new reality.


Read also: AHA 2020 | POLYPILL: One Pill Plus Aspirin to Treat Everything.


The analysis included 62,083 patients registered in the United States database who underwent TAVR between 2012 and 2017. Out of all patients, 11% needed a permanent pacemaker after the procedure (most during the index hospitalization). During the study period, implantation rates were stable (p = 0.632 for trend).

Hospitalization time was significantly shortened from a mean 6 days in 2012 to just 2 days in 2017 (p < 0.0001).


Read also: The Most Read Scientific Articles in Interventional Cardiology.


The combination of shorter hospital stays and stable pacemaker rates means many patients underwent implantation in subsequent post-discharge visits.

Patients who present a high risk of atrioventricular block after discharge, those with right-sided bundle branch block, transient blockages after the procedure, a deep implant, or an oversized valve compared with annular dimensions should be considered for remote and continuous ambulatory monitoring.

mcp-y-tavi

Original title: Shifting trends in timing of pacemaker implantation after transcatheter aortic valve replacement.

Reference: Mazzella AJ et al. Presentado en el congreso AHA 2020 y publicado simultáneamente en J Am Coll Cardiol Intv. 2020.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...